@article{11ad3442e8a0454c92f6a3bc2e1f470f,
title = "Current status of personalized medicine based on pharmacogenetics in cardiovascular medicine",
author = "Brian Tomlinson and Miao Hu and Waye, \{Mary M.Y.\} and Paul Chan and Liu, \{Zhong Min\}",
note = "Funding Information: The Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health Pharmacogenomics Research Network has been established to provide evidence-based practical guidelines from a panel of experts to facilitate the implementation and translation of pharmacogenomic knowledge from bench to bedside [4]. In the cardiovascular field, there has been a tremendous amount of work resulting in numerous publications which have been reviewed by the CPIC resulting in implementation guidelines for warfarin [5], clopidogrel [6,7], and simvastatin [8,9]. The Implementing GeNomics In pracTicE network funded by the NIH and other US funding bodies involves six genomic medicine demonstration projects which will help to implement the use of genomic information in patient care [10].",
year = "2016",
month = jan,
day = "2",
doi = "10.1080/23808993.2016.1142826",
language = "English",
volume = "1",
pages = "5--8",
journal = "Expert Review of Precision Medicine and Drug Development",
issn = "2380-8993",
publisher = "Taylor and Francis Ltd.",
number = "1",
}